{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T12:38:23Z","timestamp":1776775103797,"version":"3.51.2"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004169","name":"Meiji Seika Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004169","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jiac.2026.102953","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T07:54:36Z","timestamp":1774338876000},"page":"102953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of booster vaccinations and prior infection on COVID-19 symptom resolution during the 2025 NB.1.8.1-dominant epidemic in Japan: A retrospective multicenter study"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6340-3912","authenticated-orcid":false,"given":"Takuma","family":"Bando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3548-4231","authenticated-orcid":false,"given":"Hideyuki","family":"Ikematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keigo","family":"Shibao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsunari","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichi","family":"Harashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tokunao","family":"Amemiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshitaka","family":"Oribe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinro","family":"Matsuura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Doniwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woon Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Asamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2026.102953_bib1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.35772\/ghm.2025.01004","article-title":"Large-scale screening of SARS-CoV-2 variants in Tokyo, Japan: a 3-year and 9-month longitudinal survey","volume":"7","author":"Takeuchi","year":"2025","journal-title":"Glob Health Med"},{"key":"10.1016\/j.jiac.2026.102953_bib2","doi-asserted-by":"crossref","first-page":"e256","DOI":"10.1016\/S2214-109X(24)00419-4","article-title":"Emergence and spread of the SARS-CoV-2 omicron (BA.1) variant across Africa: an observational study","volume":"13","author":"Fischer","year":"2025","journal-title":"Lancet Global Health"},{"key":"10.1016\/j.jiac.2026.102953_bib3","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/s41467-024-46490-7","article-title":"Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86\/JN.1 lineages combining increased fitness and antibody evasion","volume":"15","author":"Planas","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiac.2026.102953_bib4","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2026.102953_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2026.102953_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa2116185","article-title":"Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico","volume":"386","author":"Dunkle","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2026.102953_bib7","first-page":"400","article-title":"Observational study of the COVID-19 vaccine booster's effect on the incidence of infection and the development of fever during the sixth COVID-19 wave in Japan","volume":"37","author":"Bando","year":"2023","journal-title":"JJPA"},{"key":"10.1016\/j.jiac.2026.102953_bib8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.11150\/kansenshogakuzasshi.e24011","article-title":"Impact of the number of vaccinations on the duration of fever and symptoms in adult patients with mild COVID-19 during the period of spread of the omicron variant of SARS-CoV-2 in Japan","volume":"98","author":"Goto","year":"2024","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.jiac.2026.102953_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2025.102798","article-title":"The effectiveness of repeated vaccination for COVID-19 symptom resolution during the KP.3-dominant epidemic period in Japan: a retrospective multicenter study","volume":"31","author":"Bando","year":"2025","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2026.102953_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(25)00356-1","article-title":"Virological characteristics of the SARS-CoV-2 NB.1.8.1 variant","volume":"25","author":"Uriu","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2026.102953_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116715","article-title":"Antibody evasion and receptor binding of SARS-CoV-2 LP.8.1.1, NB.1.8.1, XFG, and related subvariants","volume":"44","author":"Mellis","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.jiac.2026.102953_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02901-25","article-title":"Antibody responses to SARS-CoV-2 variants LP.8.1, LF.7.1, NB.1.8.1, XFG, and BA.3.2 following KP.2 monovalent mRNA vaccination","volume":"17","author":"Abbad","year":"2026","journal-title":"mBio"},{"key":"10.1016\/j.jiac.2026.102953_bib13","doi-asserted-by":"crossref","first-page":"e732","DOI":"10.1016\/S1473-3099(24)00688-1","article-title":"Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC","volume":"24","author":"Arora","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2026.102953_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126961","article-title":"mRNA-1273 vaccines adapted to JN.1 or KP.2 elicit cross-neutralizing responses against the JN.1 sublineages of SARS-CoV-2 in mice","volume":"54","author":"Lee","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.jiac.2026.102953_bib16","article-title":"Diagnosis of COVID-19: is fever the best indicator of COVID-19 in vaccinated SARS-CoV-2-positive adults?","volume":"16","author":"Inaba","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.jiac.2026.102953_bib17","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","article-title":"Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and Delta variant dominance: a prospective observational study from the ZOE COVID study","volume":"399","author":"Menni","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2026.102953_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.jiac.2026.102953_bib19","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3201\/eid3007.231723","article-title":"Prevalence of and risk factors for post-COVID-19 condition during the Omicron BA.5\u2013dominant wave in Japan","volume":"30","author":"Iba","year":"2024","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jiac.2026.102953_bib20","article-title":"Effectiveness of COVID-19 vaccination and prior infections to reduce long COVID risk during the pre-omicron and omicron period","author":"Carazo","year":"2025","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.102953_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s43856-025-00894-8","article-title":"Serum anti-nucleocapsid antibody correlates of protection from SARS-CoV-2 re-infection regardless of symptoms or immune history","volume":"5","author":"Miyamoto","year":"2025","journal-title":"Commun Med"},{"key":"10.1016\/j.jiac.2026.102953_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2024.100489","article-title":"Reduction of adverse reactions and correlation between post-vaccination fever and specific antibody response across successive SARS-CoV-2 mRNA vaccinations","volume":"18","author":"Tani","year":"2024","journal-title":"Vaccine X"},{"key":"10.1016\/j.jiac.2026.102953_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65302-0","article-title":"A systematic review and meta-analysis of the impact of vaccination on prevention of long COVID","volume":"16","author":"Green","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiac.2026.102953_bib24","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2026.102953_bib25","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.resinv.2025.09.012","article-title":"Differences between influenza and COVID-19 patients who required hospitalization: a study of the 2024\u20132025 season","volume":"63","author":"Miyashita","year":"2025","journal-title":"Respir Investig"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26000516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:42:23Z","timestamp":1776771743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26000516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1341321X26000516"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102953","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of booster vaccinations and prior infection on COVID-19 symptom resolution during the 2025 NB.1.8.1-dominant epidemic in Japan: A retrospective multicenter study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.102953","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102953"}}